Urinary EGF and MCP-1 and risk of CKD after cardiac surgery

JCI Insight. 2021 Jun 8;6(11):e147464. doi: 10.1172/jci.insight.147464.

Abstract

BACKGROUNDAssessment of chronic kidney disease (CKD) risk after acute kidney injury (AKI) is based on limited markers primarily reflecting glomerular function. We evaluated markers of cell integrity (EGF) and inflammation (monocyte chemoattractant protein-1, MCP-1) for predicting long-term kidney outcomes after cardiac surgery.METHODSWe measured EGF and MCP-1 in postoperative urine samples from 865 adults who underwent cardiac surgery at 2 sites in Canada and the United States and assessed EGF and MCP-1's associations with the composite outcome of CKD incidence or progression. We used single-cell RNA-Seq (scRNA-Seq) of AKI patient biopsies to perform transcriptomic analysis of programs corregulated with the associated genes.RESULTSOver a median (IQR) follow-up of 5.8 (4.2-7.1) years, 266 (30.8%) patients developed the composite CKD outcome. Postoperatively, higher levels of urinary EGF were protective and higher levels of MCP-1 were associated with the composite CKD outcome (adjusted HR 0.83, 95% CI 0.73-0.95 and 1.10, 95% CI 1.00-1.21, respectively). Intrarenal scRNA-Seq transcriptomes in patients with AKI-defined cell populations revealed concordant changes in EGF and MCP-1 levels and underlying molecular processes associated with loss of EGF expression and gain of CCL2 (encoding MCP-1) expression.CONCLUSIONUrinary EGF and MCP-1 were each independently associated with CKD after cardiac surgery. These markers may serve as noninvasive indicators of tubular damage, supported by tissue transcriptomes, and provide an opportunity for novel interventions in cardiac surgery.TRIAL REGISTRATIONClinicalTrials.gov NCT00774137.FUNDINGThe NIH funded the TRIBE-AKI Consortium and Kidney Precision Medicine Project. Yale O'Brien Kidney Center, American Heart Association, Patterson Trust Fund, Dr. Adam Linton Chair in Kidney Health Analytics, Canadian Institutes of Health Research, ICES, Ontario Ministry of Health and Long-Term Care, Academic Medical Organization of Southwestern Ontario, Schulich School of Medicine & Dentistry, Western University, Lawson Health Research Institute, Chan Zuckerberg Initiative Human Cell Atlas Kidney Seed Network.

Keywords: Cardiovascular disease; Chronic kidney disease; Molecular genetics; Nephrology.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / epidemiology*
  • Acute Kidney Injury / genetics
  • Acute Kidney Injury / urine
  • Aged
  • Aged, 80 and over
  • Cardiac Surgical Procedures*
  • Chemokine CCL2 / genetics
  • Chemokine CCL2 / urine*
  • Disease Progression
  • Epidermal Growth Factor / genetics
  • Epidermal Growth Factor / urine*
  • Female
  • Gene Expression Profiling
  • Humans
  • Incidence
  • Male
  • Postoperative Complications / epidemiology*
  • Postoperative Complications / genetics
  • Postoperative Complications / urine
  • Proportional Hazards Models
  • RNA, Messenger / metabolism
  • RNA-Seq
  • Renal Insufficiency, Chronic / epidemiology*
  • Renal Insufficiency, Chronic / genetics
  • Renal Insufficiency, Chronic / urine
  • Single-Cell Analysis

Substances

  • CCL2 protein, human
  • Chemokine CCL2
  • RNA, Messenger
  • Epidermal Growth Factor

Associated data

  • ClinicalTrials.gov/NCT00774137